Riskpilot← Back to searchSign inGet full accessOSLO ØRE NESE HALS AS
ASActiveOrg 989431641Valkyriegata 8, 0366 OsloMedical specialists activities · NACE 8622Est. 20068 employees
Revenue 2025
NOK 9,7M
+4% vs 2024
EBITDA margin
0.4%
+74% vs 2024
Equity ratio
12.4%
Financial strength
Net profit 2025
NOK 0
8 employees
| Revenue | NOK 9,7M | +4% |
| EBITDA | NOK 36K | +74% |
| Net profit | NOK 0 | — |
| Total assets | NOK 1M | -17% |
| Equity | NOK 129K | +0% |
| Employees | 8 | — |
Legal name
OSLO ØRE NESE HALS AS
Org number
989431641
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
1. mars 2006
Share capital
NOK 102 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Å yte legetjenester, investere i eiendom og aksjer mv, samt å investere i andre selskaper som driver med det samme og alt hva dermed står i forbindelse.
Address
Valkyriegata 8, 0366 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7 275 | 8 006 | 8 802 | 9 381 | 9 710 |
| Staff expenses | −4 066 | −4 379 | −4 730 | −5 212 | −5 321 |
| EBITDA | 37 | 42 | 34 | 21 | 36 |
| Depreciation & amort. | −37 | −42 | −31 | −23 | −38 |
| EBIT | 1 | 0 | 3 | −2 | −1 |
| Net financials | −0 | −0 | −3 | 2 | 1 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | 0 | 0 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 097 | 1 268 | 1 471 | 1 251 | 1 039 |
| Equity | 129 | 129 | 129 | 129 | 129 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 968 | 1 138 | 1 342 | 1 122 | 910 |
| Total debt | 968 | 1 138 | 1 342 | 1 122 | 910 |
EBITDA margin
0.4%
This company
15.8%
Market median
-97% vs market
20212025
Equity ratio
12.4%
This company
38.2%
Market median
-68% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
9.34×
This company
1.12×
Market median
+734% vs market
20212025
Debt / equity
7.05×
This company
0.62×
Market median
-1037% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GT Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33% | 33.33% | 2022 | |
| Company | 26.47% | 26.47% | 2022 | |
| Company | 6.86% | 6.86% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bror Løvdal As
OSLO ØRE NESE HALS AS Board members of OSLO ØRE NESE HALS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Geir Thorvald Follestad | Chief Executive Officer | 0 companies |
| Oskar Dagner Løvdal | Board of Directors | 0 companies |
| Fridtjof Walseth | Board of Directors | 0 companies |
| Stine Fryjordet Wiik | Board of Directors | 0 companies |